ATE239454T1 - Orale morphinzubereitung in teilchenform - Google Patents
Orale morphinzubereitung in teilchenformInfo
- Publication number
- ATE239454T1 ATE239454T1 AT97947848T AT97947848T ATE239454T1 AT E239454 T1 ATE239454 T1 AT E239454T1 AT 97947848 T AT97947848 T AT 97947848T AT 97947848 T AT97947848 T AT 97947848T AT E239454 T1 ATE239454 T1 AT E239454T1
- Authority
- AT
- Austria
- Prior art keywords
- morphine
- patient
- particle form
- oral morphine
- core
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6252597P | 1997-10-17 | 1997-10-17 | |
US08/977,965 US6066339A (en) | 1997-10-17 | 1997-11-25 | Oral morphine multiparticulate formulation |
PCT/IE1997/000082 WO1999020255A1 (en) | 1997-10-17 | 1997-12-05 | Oral morphine multiparticulate formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE239454T1 true ATE239454T1 (de) | 2003-05-15 |
Family
ID=26742378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97947848T ATE239454T1 (de) | 1997-10-17 | 1997-12-05 | Orale morphinzubereitung in teilchenform |
Country Status (11)
Country | Link |
---|---|
US (1) | US6066339A (de) |
EP (1) | EP1023051B1 (de) |
JP (1) | JP4535613B2 (de) |
AT (1) | ATE239454T1 (de) |
AU (1) | AU5408098A (de) |
CA (1) | CA2306333C (de) |
DE (1) | DE69721845T2 (de) |
DK (1) | DK1023051T3 (de) |
ES (1) | ES2199378T3 (de) |
PT (1) | PT1023051E (de) |
WO (1) | WO1999020255A1 (de) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2774910B1 (fr) * | 1998-02-16 | 2001-09-07 | Ethypharm Lab Prod Ethiques | Microgranules de sulfate de morphine, procede de fabrication et preparations pharmaceutiques |
US20080102121A1 (en) * | 1998-11-02 | 2008-05-01 | Elan Pharma International Limited | Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone |
IE990406A1 (en) * | 1999-05-20 | 2000-12-27 | Elan Corp Plc | Multiparticulate controlled release selective serotonin reuptake inhibitor formulations. |
EP1064937A1 (de) * | 1999-06-28 | 2001-01-03 | Sanofi-Synthelabo | Pharmazeutische Zusammensetzungen mit kontrollierten Freigabe enthaltend ein Hypnotikum mit kurzer Wirkung oder deren Salze |
KR101216270B1 (ko) | 1999-10-29 | 2012-12-31 | 유로-셀티크 소시에떼 아노뉨 | 서방성 하이드로코돈 제형 |
AU2002227383B2 (en) | 2000-10-30 | 2004-07-08 | Euro-Celtique S.A. | Controlled release hydrocodone formulations |
US20110104214A1 (en) | 2004-04-15 | 2011-05-05 | Purdue Pharma L.P. | Once-a-day oxycodone formulations |
UA81224C2 (uk) * | 2001-05-02 | 2007-12-25 | Euro Celtic S A | Дозована форма оксикодону та її застосування |
ES2361148T3 (es) * | 2001-05-11 | 2011-06-14 | Endo Pharmaceuticals Inc. | Forma de dosificación de opioides de liberación controlada resistente al abuso. |
WO2003002100A1 (en) * | 2001-06-26 | 2003-01-09 | Farrell John J | Tamper-proof narcotic delivery system |
US20030068375A1 (en) | 2001-08-06 | 2003-04-10 | Curtis Wright | Pharmaceutical formulation containing gelling agent |
US20040253310A1 (en) | 2001-09-21 | 2004-12-16 | Gina Fischer | Morphine polymer release system |
WO2003024429A1 (en) | 2001-09-21 | 2003-03-27 | Egalet A/S | Polymer release system |
BR0311327A (pt) * | 2002-05-31 | 2005-02-22 | Desitin Arzneimittel Gmbh | Composição farmacêutica contendo oxcarbazepina com liberação sustentada de um ingrediente ativo |
ES2208096B2 (es) * | 2002-08-14 | 2005-04-16 | Universidad De Sevilla | Composicion farmaceutica y medicamento de liberacion controlada de morfina basado en un complejo de morfina con un polimero acrilico. |
EP1537880A4 (de) | 2002-09-11 | 2009-07-01 | Takeda Pharmaceutical | PRûPARAT MIT VERZ GERTER FREISETZUNG |
US20050020613A1 (en) * | 2002-09-20 | 2005-01-27 | Alpharma, Inc. | Sustained release opioid formulations and method of use |
EP1610767B1 (de) | 2003-03-26 | 2011-01-19 | Egalet A/S | Morphin-system mit kontrollierter freisetzung |
US8158149B2 (en) * | 2004-05-12 | 2012-04-17 | Chelsea Therapeutics, Inc. | Threo-DOPS controlled release formulation |
US20060105036A1 (en) | 2003-05-12 | 2006-05-18 | Stephen Peroutka | Threo-dops controlled release formulation |
US20090214644A1 (en) * | 2003-07-31 | 2009-08-27 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations with reduced adverse effects |
US20050025825A1 (en) * | 2003-07-31 | 2005-02-03 | Xanodyne Pharmacal, Inc. | Tranexamic acid formulations with reduced adverse effects |
CA2541371C (en) * | 2003-10-03 | 2014-12-16 | Atul M. Mehta | Extended release formulations of opioids and method of use thereof |
US7947739B2 (en) | 2004-03-04 | 2011-05-24 | Ferring B.V. | Tranexamic acid formulations |
US20090215898A1 (en) * | 2004-03-04 | 2009-08-27 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations |
US20050244495A1 (en) | 2004-03-04 | 2005-11-03 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations |
US8022106B2 (en) * | 2004-03-04 | 2011-09-20 | Ferring B.V. | Tranexamic acid formulations |
US20050245614A1 (en) * | 2004-03-04 | 2005-11-03 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations |
EP1765292B1 (de) | 2004-06-12 | 2017-10-04 | Collegium Pharmaceutical, Inc. | Gegen missbrauch gesicherte arzneimittelformulierungen |
CA2584547C (en) * | 2004-10-19 | 2014-07-08 | Miha Vrbinc | Solid pharmaceutical composition comprising donepezil hydrochloride |
US20070053868A1 (en) | 2005-03-08 | 2007-03-08 | Banner Pharmacaps, Inc. | Solvent system for enhancing the solubility of pharmaceutical agents |
CA2578626C (en) * | 2005-06-27 | 2011-07-19 | Biovail Laboratories International S.R.L. | Modified-release formulations of a bupropion salt |
US20070190141A1 (en) * | 2006-02-16 | 2007-08-16 | Aaron Dely | Extended release opiate composition |
FR2897267A1 (fr) * | 2006-02-16 | 2007-08-17 | Flamel Technologies Sa | Formes pharmaceutiques multimicroparticulaires pour administration per os |
US7872013B2 (en) * | 2006-08-16 | 2011-01-18 | Auspex Pharmaceuticals, Inc. | Preparation and utility of opioid analgesics |
SA07280459B1 (ar) | 2006-08-25 | 2011-07-20 | بيورديو فارما إل. بي. | أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني |
CA2618240C (en) | 2006-11-17 | 2015-01-20 | Supernus Pharmaceuticals, Inc. | Sustained-release formulations of topiramate |
AU2008258596B2 (en) | 2007-06-04 | 2013-02-14 | Egalet Ltd | Controlled release pharmaceutical compositions for prolonged effect |
US20090004281A1 (en) * | 2007-06-26 | 2009-01-01 | Biovail Laboratories International S.R.L. | Multiparticulate osmotic delivery system |
PL2187873T3 (pl) | 2007-08-13 | 2019-01-31 | Abuse Deterrent Pharmaceutical Llc | Leki odporne na nadużywanie, metoda stosowania i metoda wytwarzania |
US20100034968A1 (en) * | 2008-08-07 | 2010-02-11 | Vector Corporation | Polymer coating process using dry glidant in a rotor processor |
US20100034967A1 (en) * | 2008-08-07 | 2010-02-11 | Vector Corporation | Dry polymer layering using a rotor processor |
US8807070B2 (en) * | 2008-08-07 | 2014-08-19 | Vector Corporation | Rotor processor for dry powders |
EP2393484A1 (de) | 2009-02-06 | 2011-12-14 | Egalet Ltd. | Gegen missbrauch durch alkoholeinnahme widerstandsfähige zusammensetzung mit unmittelbarer freisetzung |
US20100280117A1 (en) * | 2009-04-30 | 2010-11-04 | Xanodyne Pharmaceuticals, Inc. | Menorrhagia Instrument and Method for the Treatment of Menstrual Bleeding Disorders |
CA2766179A1 (en) | 2009-06-24 | 2010-12-29 | Egalet Ltd. | Controlled release formulations |
US10668060B2 (en) | 2009-12-10 | 2020-06-02 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
CA2991217C (en) | 2010-12-22 | 2020-06-09 | Purdue Pharma L.P. | Encased tamper resistant controlled release dosage forms |
JP5638151B2 (ja) | 2010-12-23 | 2014-12-10 | パーデュー、ファーマ、リミテッド、パートナーシップ | 不正加工抵抗性の(tamperresistant)固形経口剤形 |
GB201202433D0 (en) | 2012-02-13 | 2012-03-28 | Diurnal Ltd | Controlled drug release |
EP2877161A1 (de) | 2012-07-06 | 2015-06-03 | Egalet Ltd. | Missbrauchssichere pharmazeutische zusammensetzungen zur kontrollierten freisetzung |
BR112015000320B1 (pt) | 2012-07-12 | 2023-03-07 | SpecGx LLC | Composições farmacêuticas dissuasivas de abuso e seu processo de preparação |
US10322120B2 (en) | 2012-07-31 | 2019-06-18 | Persion Pharmaceuticals Llc | Treating pain in patients with hepatic impairment |
US10751287B2 (en) | 2013-03-15 | 2020-08-25 | Purdue Pharma L.P. | Tamper resistant pharmaceutical formulations |
US11571390B2 (en) | 2013-03-15 | 2023-02-07 | Othemo Life Sciences, Inc. | Abuse deterrent compositions and methods of use |
US9132096B1 (en) | 2014-09-12 | 2015-09-15 | Alkermes Pharma Ireland Limited | Abuse resistant pharmaceutical compositions |
US10729685B2 (en) | 2014-09-15 | 2020-08-04 | Ohemo Life Sciences Inc. | Orally administrable compositions and methods of deterring abuse by intranasal administration |
WO2017222575A1 (en) | 2016-06-23 | 2017-12-28 | Collegium Pharmaceutical, Inc. | Process of making more stable abuse-deterrent oral formulations |
WO2018208241A1 (en) | 2017-05-10 | 2018-11-15 | İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi | Formulation and optimization of controlled release tablets of morphine sulphate |
GB201716716D0 (en) * | 2017-10-12 | 2017-11-29 | Univ Of Hertfordshire Higher Education Corporation | Method for coating particles |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE48715B1 (en) * | 1978-12-22 | 1985-05-01 | Elan Corp Plc | New galencial forms for administration of medicaments by oral route,with programmed release and processes for preparing same |
FR2525108B1 (fr) * | 1982-04-19 | 1989-05-12 | Elan Corp Ltd | Medicaments a haut degre de solubilite et procede pour leur obtention |
IE55745B1 (en) * | 1983-04-06 | 1991-01-02 | Elan Corp Plc | Sustained absorption pharmaceutical composition |
PH18946A (en) * | 1983-04-21 | 1985-11-14 | Elan Corp Plc | Controlled absorption pharmaceutical composition |
IE56459B1 (en) * | 1983-12-21 | 1991-08-14 | Elan Corp Ltd | Controlled absorption pharmaceutical formulation |
US4894240A (en) * | 1983-12-22 | 1990-01-16 | Elan Corporation Plc | Controlled absorption diltiazem formulation for once-daily administration |
US4917899A (en) * | 1983-12-22 | 1990-04-17 | Elan Corporation Plc | Controlled absorption diltiazem formulation |
US5002776A (en) * | 1983-12-22 | 1991-03-26 | Elan Corporation, Plc | Controlled absorption diltiazem formulations |
IE56999B1 (en) * | 1983-12-22 | 1992-03-11 | Elan Corp Plc | Pharmaceutical formulation |
US5364620A (en) * | 1983-12-22 | 1994-11-15 | Elan Corporation, Plc | Controlled absorption diltiazem formulation for once daily administration |
US4826688A (en) * | 1985-11-13 | 1989-05-02 | 501 Elan Corporation PLC. | Controlled absorption pharmaceutical formulation |
IE58401B1 (en) * | 1986-06-20 | 1993-09-08 | Elan Corp Plc | Controlled absorption pharmaceutical composition |
US4970075A (en) * | 1986-07-18 | 1990-11-13 | Euroceltique, S.A. | Controlled release bases for pharmaceuticals |
US5336504A (en) * | 1987-10-16 | 1994-08-09 | Elan Corporation, Plc | Diltiazem formulations and methods of treatment |
US5219621A (en) * | 1987-10-16 | 1993-06-15 | Elan Corporation, Plc | Methods of treatment with diltiazem formulations |
SE8803822D0 (sv) * | 1988-10-26 | 1988-10-26 | Novel dosage form | |
US5178868A (en) * | 1988-10-26 | 1993-01-12 | Kabi Pharmacia Aktiebolaq | Dosage form |
US5202128A (en) * | 1989-01-06 | 1993-04-13 | F. H. Faulding & Co. Limited | Sustained release pharmaceutical composition |
US5330766A (en) * | 1989-01-06 | 1994-07-19 | F. H. Faulding & Co. Limited | Sustained release pharmaceutical composition |
CA2007181C (en) * | 1989-01-06 | 1998-11-24 | Angelo Mario Morella | Sustained release pharmaceutical composition |
JPH0674206B2 (ja) * | 1989-12-28 | 1994-09-21 | 田辺製薬株式会社 | 放出制御型製剤およびその製法 |
US5229131A (en) * | 1990-02-05 | 1993-07-20 | University Of Michigan | Pulsatile drug delivery system |
DE69229881T2 (de) * | 1991-10-04 | 1999-12-09 | Yoshitomi Pharmaceutical | Tablette mit verzögerter freisetzung |
US5286493A (en) * | 1992-01-27 | 1994-02-15 | Euroceltique, S.A. | Stabilized controlled release formulations having acrylic polymer coating |
US5478577A (en) * | 1993-11-23 | 1995-12-26 | Euroceltique, S.A. | Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
US5273760A (en) * | 1991-12-24 | 1993-12-28 | Euroceltigue, S.A. | Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
SE9202250D0 (sv) * | 1992-07-29 | 1992-07-29 | Gacell Lab Ab | Controlled release morphine preparation |
US5656291A (en) * | 1994-03-16 | 1997-08-12 | Pharmacia & Upjohn Aktiebolag | Controlled release preparation |
SE9301057L (sv) * | 1993-03-30 | 1994-10-01 | Pharmacia Ab | Beredning med kontrollerad frisättning |
IL109944A (en) * | 1993-07-01 | 1998-12-06 | Euro Celtique Sa | Continuous release dosage form containing morphine and a method of preparing such sustained release unit dosage forms |
IL110014A (en) * | 1993-07-01 | 1999-11-30 | Euro Celtique Sa | Solid controlled-release oral dosage forms of opioid analgesics |
EP1442745A1 (de) * | 1993-10-07 | 2004-08-04 | Euro-Celtique | Oral anzuwendende opioidhaltige Zusammensetzungen mit verlängerter Wirkung |
US5411745A (en) * | 1994-05-25 | 1995-05-02 | Euro-Celtique, S.A. | Powder-layered morphine sulfate formulations |
US5460826A (en) * | 1994-06-27 | 1995-10-24 | Alza Corporation | Morphine therapy |
IL116674A (en) * | 1995-01-09 | 2003-05-29 | Mendell Co Inc Edward | Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof |
-
1997
- 1997-11-25 US US08/977,965 patent/US6066339A/en not_active Expired - Lifetime
- 1997-12-05 PT PT97947848T patent/PT1023051E/pt unknown
- 1997-12-05 ES ES97947848T patent/ES2199378T3/es not_active Expired - Lifetime
- 1997-12-05 DE DE69721845T patent/DE69721845T2/de not_active Expired - Lifetime
- 1997-12-05 AT AT97947848T patent/ATE239454T1/de active
- 1997-12-05 JP JP2000516654A patent/JP4535613B2/ja not_active Expired - Fee Related
- 1997-12-05 AU AU54080/98A patent/AU5408098A/en not_active Abandoned
- 1997-12-05 WO PCT/IE1997/000082 patent/WO1999020255A1/en active IP Right Grant
- 1997-12-05 EP EP97947848A patent/EP1023051B1/de not_active Expired - Lifetime
- 1997-12-05 DK DK97947848T patent/DK1023051T3/da active
- 1997-12-05 CA CA002306333A patent/CA2306333C/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO1999020255A1 (en) | 1999-04-29 |
JP2001520187A (ja) | 2001-10-30 |
EP1023051A1 (de) | 2000-08-02 |
PT1023051E (pt) | 2003-09-30 |
CA2306333C (en) | 2006-10-10 |
EP1023051B1 (de) | 2003-05-07 |
DE69721845T2 (de) | 2004-02-19 |
DE69721845D1 (de) | 2003-06-12 |
DK1023051T3 (da) | 2003-09-01 |
CA2306333A1 (en) | 1999-04-29 |
ES2199378T3 (es) | 2004-02-16 |
AU5408098A (en) | 1999-05-10 |
JP4535613B2 (ja) | 2010-09-01 |
US6066339A (en) | 2000-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE239454T1 (de) | Orale morphinzubereitung in teilchenform | |
NZ509028A (en) | Stable extended release oral dosage composition comprising a pseudoephedrine-containing core, the core being uniformly covered with a desloratadine-containing film | |
CA2395333A1 (en) | Hydrogel-driven drug dosage form | |
MY125548A (en) | Water soluble film for oral administration with instant wettability | |
ATE213629T1 (de) | Milnacipranhaltige darreichungsform mit verzögerter wirkstoffabgabe | |
AP2001002237A0 (en) | Hydrogel-driven drug dosage form. | |
ATE391496T1 (de) | Geschmacksmaskierte pharmazeutische formulierungen | |
CA2281420A1 (en) | Preparation of pharmaceutically-active granules | |
WO2001019337A3 (en) | Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing | |
PL352873A1 (en) | New formulation | |
IL211075A (en) | Multi-component preparation with irregular release | |
HK1015269A1 (en) | Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof | |
WO2000019984A3 (de) | Überzogene arzneiformen mit kontrollierter wirkstoffabgabe | |
CA2348090A1 (en) | Oral pulsed dose drug delivery system | |
SE8602722D0 (sv) | Hallbara administreringsformer | |
GEP20043198B (en) | Extended Release Formulation | |
ES2130081A1 (es) | Comprimido de maleato de trimebutina con recubrimiento laminar. | |
CA2383212A1 (en) | Controlled release oral dosage suitable for oral administration | |
CA2417887A1 (en) | Particulate composition of eletriptan | |
CA2340898A1 (en) | Compositions and methods for treating intracellular infections | |
DE69827466D1 (de) | Geschmacksneutrale pharmazeutische zusammensetzungen | |
MX9803918A (es) | Tabletas de liberacion rapida comprendiendo acido tolfenamico o una sal farmaceuticamente aceptable del mismo como ingrediente activo y un metodo para la preparacion de dicha tableta. | |
WO2001085188A3 (en) | Use of echinacea as a hematinic agent | |
CA2281474A1 (en) | Dosage forms exhibiting multiphasic release kinetics and methods of manufacture thereof | |
EP0761209A3 (de) | Ranitidinformulierungen mit gesteuerter Freisetzung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1023051 Country of ref document: EP |
|
EEIH | Change in the person of patent owner |